Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29449737 | 0.98 | TRPM8 (0.50) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL25349880 | 0.98 | TRPM8 (0.50) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL9080881 | 0.87 | TRPM8 (0.60) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL27969261 | 0.78 | TRPA1 (0.47) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL29444900 | 0.78 | TRPM8 (0.39) | TRPM8TRPA1EPHX1ALDH1A1 | |
| SCHEMBL8548065 | 0.77 | TRPM8 (0.59) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL27969212 | 0.74 | TRPA1 (0.47) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL7101233 | 0.74 | TRPA1 (0.40) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL9487930 | 0.73 | TRPM8 (0.55) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL9340641 | 0.73 | TRPM8 (0.55) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240293356-A1 | Cannabinoid Formulations | ENDOCANNA HEALTH INC (US) | 2024-09-05 | — | — | US | disclosed |
| US-11857530-B2 | Cannabinoid formulations | ENDOCANNA HEALTH, INC. (US) | 2024-01-02 | — | — | US | disclosed |
| EP-3703672-A1 | CANNABINOID FORMULATIONS | Endocanna Health, Inc. (US) | 2020-09-09 | — | — | EP | disclosed |
| US-20200253921-A1 | Cannabinoid Formulations | ENDOCANNA HEALTH, INC. | 2020-08-13 | — | — | US | disclosed |